Aspirine en prévention cardiovasculaire primaire : la fin d’une époque ? [Aspirin for primary cardiovascular prevention : the end of an era ?]
Fiche du document
4 mars 2020
- doi: 10.53738/REVMED.2020.16.684.0459
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2020.16.684.0459
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32134226
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_7A4F74482DF52
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Quantitative analysis Quantitative chemical analysis Erythrocytes--Sedimentation Erythrocyte sedimentation Blood sedimentation ESR (Hematology) Erythrocyte sedimentation rate Acetylsalicylic acid Methods of analysis Analysis and chemistry Analytical methods Chemical analysis Analysis methods Analysis and examination Acetilsalicílico Ácido acetilsalicílico Análisis cuantitativo Química analítica cuantitativa Vitesse de sédimentation érythrocytaire VSG Vitesse de sédimentation Vitesse de sédimentation des hématies Vitesse de sédimentation sanguine Temps de sédimentation VS Acide acétyl-salicylique Acide acétylsalicylique RN 50-78-2 Essais quantitatifs (chimie) Chimie analytique quantitative Dosage Analyse chimique Dosage Sciences de la gestion Gestion, Sciences de la Sciences de gestion Techniques de gestion Direction Management Prévention et mesures de lutte Programmes de préventionCiter ce document
G. Ravach et al., « Aspirine en prévention cardiovasculaire primaire : la fin d’une époque ? [Aspirin for primary cardiovascular prevention : the end of an era ?] », Serveur académique Lausannois, ID : 10.53738/REVMED.2020.16.684.0459
Métriques
Partage / Export
Résumé
Low-dose aspirin in primary prevention of cardiovascular disease is still debated. Recent clinical trials of aspirin vs placebo reported an unfavourable risk-benefit ratio with an increase in major bleedings without reduction on the occurrence of non-fatal cardiovascular events. These studies also highlight that current cardiovascular risk calculators overestimate cardiovascular risk, which is probably related to the improvement in the management of cardiovascular risk factors over the last decades. In accordance with European cardiovascular prevention recommendations, aspirin should not be prescribed for the primary prevention of cardiovascular disease.